FOUND: How is edwards lifesciences stock performance compared to other medical device stocks - What They Never Told You

With a market cap of $50.3 billion, Irvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies aimed at treating advanced cardiovascular diseases. It operates as the world’s leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.

Companies worth $10 billion or more are generally referred to as “large-cap stocks.” EW fits right into that category, with its market cap exceeding the threshold, reflecting its substantial size, influence, and dominance in the healthcare sector.